Prostamax is a bioengineered active peptide designed for treating various prostate diseases.
Developed through extensive molecular-level research into the pathological mechanisms of these disorders, it incorporates partial sequences from specific growth factors, anti-inflammatory peptides, or signal-modulating peptides.
Amino acid substitutions, filaharana truncation, and cyclization are used to enhance its stability, bioavailability, and targeting; reduction in degradation and consequently a prolonged half-life are direct outcomes of this process.
Specific action on prostate tissue is achieved.
ankapobeny, Prostamax represents a multi-mechanism, synergistic bioactive solution to improving male prostate physiological health.
filaharana
Lys-Glu-Asp-Pro
CAS laharana
/
Formula molekiola
C20H33N5O9
Lanja molekiola
487.51
Research Of Prostamax Peptide
1.Mekanisma amin'ny asa sy ny vokatry ny fitsaboana
Inhibiting key inflammatory signaling pathways within the prostate itself is one of its primary modes of operation – critical inflammatory factors exhibit significantly suppressed expression.
Effective alleviation of all forms of inflammatory conditions, associated swelling and subsequent pain, ensue.
Modulation ny androgen receptor nidika (or direct influence on 5α-reductase asa) regulates DHT (Dihydrotestosterone) famokarana (the more potent form of testosterone) and effectively controls epithelial cell proliferation.
Excessive proliferation caused by unregulated DHT is thus inhibited, lower urinary tract symptoms (LUTS) being a direct result of prostate enlargement.
Studies have also indicated significant potential for Prostamax in promoting apoptosis of prostate cells, angiogenesis inhibition, and comprehensive antioxidant/anti-inflammatory defense mechanisms.
2.Regulating Hormonal Pathways
Araka ny voalaza etsy ambony, the conversion of testosterone to DHT is pivotal to its action.
Aberrant proliferation is significantly reversed by this process.
3.Anti-inflammatory and Antioxidant Effects
The aforementioned inflammatory and oxidative damage is mitigated.
4.Anti-Proliferative Function
Cell cycle arrest (G1 phase) is a demonstrated effect of Prostamax treatment, and as a result of all the above, a restored physiological state of the prostate can be achieved.
Pressure on the urethra and bladder, and associated symptoms of chronic disease, are relieved.
mpianatra amin'ny fitantanana morontsiraka
HPLC
MS
